Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections

Previous studies reported decreased mortality in patients with carbapenemase-producing Klebsiella pneumoniae bloodstream infections (BSIs) treated with combination therapy but included carbapenem-susceptible and -intermediate isolates, as per revised CLSI breakpoints. Here, we assessed outcomes in p...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Gomez-Simmonds, A., Nelson, B., Eiras, D. P., Loo, A., Jenkins, S. G., Whittier, S., Calfee, D. P., Satlin, M. J., Kubin, C. J., Furuya, E. Y.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2016
Sujets:
Clinical Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879408/
https://ncbi.nlm.nih.gov/pubmed/27044555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03007-15
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires